A

Aprea Therapeutics
D

APRE

2.67000
USD
0.03
(1.14%)
Market Closed
Volume
171
EPS
-2
Div Yield
-
P/E
-1
Market Cap
14,511,191
OverviewSignalsIdeasNews
Related Instruments
    A
    ARVN
    -0.600
    (-3.27%)
    17.750 USD
    A
    ASND
    -2.390
    (-1.54%)
    152.440 USD
    A
    ATRA
    -0.42000
    (-5.58%)
    7.11000 USD
    A
    AUTL
    0.01500
    (0.77%)
    1.96000 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    B
    BPMC
    -2.080
    (-2.20%)
    92.280 USD
    C
    CRNX
    0.660
    (1.79%)
    37.470 USD
    More
News

Title: Aprea Therapeutics

Sector: Healthcare
Industry: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.